Medios AGHAM:ILM1 +1.02%88 EBITDA Margin % is 3.71% as of Mar. 2026, which is 27% above its 10-year median of 2.92. GuruFocus rates HAM:ILM1 with a GF Score™ of 88/100 and a GF Value™ of €17.21 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 119 Medical Distribution companies, Medios AG ranks worse than 57.14% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Medios AG's EBITDA for the
three
months ended in Mar. 2026 was €20 Mil. Medios AG's Revenue for the
three
months ended in Mar. 2026 was €528 Mil. Therefore, Medios AG's EBITDA margin for the quarter that ended in Mar. 2026 was 3.71%.
Medios AG (HAM:ILM1) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Medios AG EBITDA Margin % Related Terms
Medios AG EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Medios AG's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HAM:ILM1 vs MCK, COR, CAH: EBITDA Margin % Comparison
For the Medical Distribution subindustry, Medios AG's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medios AG EBITDA Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medios AG's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Medios AG's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medios AG (HAM:ILM1) has a EBITDA Margin % of 3.71% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Medios AG and its competitors. This is 27% above median its historical median of 2.92. According to the industry distribution chart, Medios AG ranks #68 out of 119 companies in the Medical Distribution industry, placing it in the top 57.1%.
Is Medios AG's EBITDA Margin % too high?
Medios AG's current EBITDA Margin % of 3.71% is 27% above median its 10-year median of 2.92. The Medical Distribution industry median EBITDA Margin % is 4.31. Medios AG's value of 3.71% is 13.9% below this industry median. Based on the distribution chart, Medios AG ranks #68 out of 119 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Medios AG has a GF Score™ of 88/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medios AG's EBITDA Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Medios AG ranks #68 out of 119 companies for EBITDA Margin %. This places Medios AG in the lower half of its industry. The industry median EBITDA Margin % is 4.31. Medios AG's value of 3.71% is 13.9% below this benchmark. While the company's 10-year median is 2.92 vs. the industry median of 4.31, Medios AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Distribution company?
The median EBITDA Margin % among Medical Distribution companies is 4.31, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medios AG's current EBITDA Margin % of 3.71% is 13.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Medios AG and its competitors. For the Medical Distribution industry, the median EBITDA Margin % is 4.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medios AG's current EBITDA Margin % is 3.71%, which is 27% above median its own 10-year median of 2.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medios AG stock overvalued right now?
Based on GuruFocus' analysis, Medios AG (HAM:ILM1) is currently considered Significantly Undervalued. The stock's GF Value™ is €17.21, compared to a current price of €11.92 — trading 30.7% below its estimated fair value. The current EBITDA Margin % is 3.71%, which is 27% above median its 10-year median of 2.92 and 13.9% below the Medical Distribution industry median of 4.31. Medios AG's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Medios AG (HAM:ILM1), the current EBITDA Margin % is 3.71% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medios AG (HAM:ILM1) Overvalued in 2026?
Based on GuruFocus' analysis, Medios AG stock appears to be undervalued.
The current stock price of €11.92 is trading 30.7% below its estimated GF Value™ of €17.21.
GuruFocus considers Medios AG to be Significantly Undervalued.
Key valuation signals for HAM:ILM1:
EBITDA Margin %: 3.71% (27% above median its 10-year median of 2.92)
GF Value™: €17.21 vs. price of €11.92 (30.7% below fair value)
Industry Position: 13.9% below the Medical Distribution median (#68 of 119)
No single metric tells the full story. See the HAM:ILM1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medios AG is engaged as a wholesaler for pharmaceutical medicinal products. The operating segments of the company includes: Patient-Specific Therapies: This area includes the compounding of medications on behalf of pharmacies in Germany. Pharmaceautical Supply: Medios is speciality pharma supplier company in germany, producing it own production facilities, hospitals, and Pharmacies. International Business: It includes all business and activities happening in international business.
88GF Score
Get the complete analysis for HAM:ILM1
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:ILM1 has been successfully added to your 
